References
| Author (yr) | Title | Citation | Isolate |
|---|---|---|---|
| Musyoki (2012) | Genetic characterization of HIV before widespread testing of HIV vaccine candidates at a clinical trial site in Pretoria, South Africa. | ARHR | PR HIV1 group M: 25 RT HIV1 group M: 25 CA HIV1 group M: 39 |
